RU2698654C2 - Способ очистки белка слияния - Google Patents
Способ очистки белка слияния Download PDFInfo
- Publication number
- RU2698654C2 RU2698654C2 RU2017100005A RU2017100005A RU2698654C2 RU 2698654 C2 RU2698654 C2 RU 2698654C2 RU 2017100005 A RU2017100005 A RU 2017100005A RU 2017100005 A RU2017100005 A RU 2017100005A RU 2698654 C2 RU2698654 C2 RU 2698654C2
- Authority
- RU
- Russia
- Prior art keywords
- protein
- tnfr
- fusion protein
- column
- chromatography
- Prior art date
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/12—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the preparation of the feed
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
- B01D15/203—Equilibration or regeneration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/30—Partition chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3847—Multimodal interactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1919MU2014 | 2014-06-13 | ||
IN1919/MUM/2014 | 2014-06-13 | ||
PCT/IB2015/054494 WO2015189832A1 (en) | 2014-06-13 | 2015-06-13 | Process for the purification of tnfr:fc fusion protein |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2017100005A RU2017100005A (ru) | 2018-07-13 |
RU2017100005A3 RU2017100005A3 (ja) | 2019-02-28 |
RU2698654C2 true RU2698654C2 (ru) | 2019-08-28 |
Family
ID=53524922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017100005A RU2698654C2 (ru) | 2014-06-13 | 2015-06-13 | Способ очистки белка слияния |
Country Status (12)
Country | Link |
---|---|
US (1) | US10556942B2 (ja) |
EP (1) | EP3155009A1 (ja) |
JP (1) | JP6747985B2 (ja) |
CN (1) | CN106536565A (ja) |
AU (1) | AU2015273049B2 (ja) |
BR (1) | BR112016029157A8 (ja) |
CA (1) | CA2951766A1 (ja) |
MA (1) | MA40232A (ja) |
MX (1) | MX2016016318A (ja) |
PH (1) | PH12016502482A1 (ja) |
RU (1) | RU2698654C2 (ja) |
WO (1) | WO2015189832A1 (ja) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11566082B2 (en) | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
WO2016149139A1 (en) * | 2015-03-13 | 2016-09-22 | Samsung Bioepis Co., Ltd. | Anti-tnf-alpha polypeptide composition and use thereof |
US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
US11708390B2 (en) | 2016-05-11 | 2023-07-25 | Cytiva Bioprocess R&D Ab | Method of storing a separation matrix |
CN109071613A (zh) | 2016-05-11 | 2018-12-21 | 通用电气医疗集团生物工艺研发股份公司 | 分离基质 |
US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
WO2017194593A1 (en) | 2016-05-11 | 2017-11-16 | Ge Healthcare Bioprocess R&D Ab | Method of cleaning and/or sanitizing a separation matrix |
CN111344410B (zh) * | 2017-08-17 | 2023-09-15 | 济世易为生物有限公司 | 从宿主细胞半乳糖凝集素和其他污染物中纯化糖基化蛋白的方法 |
CN111032674B (zh) * | 2017-08-30 | 2024-02-27 | 阿雷斯贸易股份有限公司 | 蛋白质纯化方法 |
US11952399B2 (en) * | 2018-12-18 | 2024-04-09 | Amgen Inc. | Methods for purifying proteins |
KR102286892B1 (ko) * | 2019-07-08 | 2021-08-06 | 삼천당제약주식회사 | 안과용 단백질 제제의 정제방법 |
CN112876567A (zh) * | 2019-11-29 | 2021-06-01 | 广东菲鹏制药股份有限公司 | Fc融合蛋白及其纯化方法 |
WO2021181417A1 (en) * | 2020-03-11 | 2021-09-16 | Dr. Reddy's Laboratories Limited | METHOD OF PURIFYING AN Fc-FUSION PROTEIN |
CN113563469A (zh) * | 2020-04-28 | 2021-10-29 | 江苏中新医药有限公司 | 高回收率纯化阿达木单抗的方法 |
WO2022234412A1 (en) * | 2021-05-03 | 2022-11-10 | Lupin Limited | A process for purification of fc-fusion proteins |
WO2023095665A1 (ja) * | 2021-11-29 | 2023-06-01 | 東ソー株式会社 | 抗体の分離方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2021284C1 (ru) * | 1991-05-30 | 1994-10-15 | Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов | Способ очистки клинических фракций декстрана |
EA017152B1 (ru) * | 2006-08-28 | 2012-10-30 | Арес Трейдинг С.А. | СПОСОБ ОЧИСТКИ Fc-СОДЕРЖАЩИХ БЕЛКОВ |
US20140072560A1 (en) * | 2012-09-11 | 2014-03-13 | Coherus Biosciences, Inc. | Correctly folded etanercept in high purity and excellent yield |
WO2014078627A1 (en) * | 2012-11-19 | 2014-05-22 | Merck Sharp & Dohme Corp. | Liquid formulations for tnfr:fc fusion proteins |
US20150299249A1 (en) * | 2013-10-18 | 2015-10-22 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7294481B1 (en) | 1999-01-05 | 2007-11-13 | Immunex Corporation | Method for producing recombinant proteins |
PL215168B1 (pl) | 2002-02-27 | 2013-10-31 | Immunex Corp | Formulacja polipeptydowa |
AU2004215653B2 (en) | 2003-02-28 | 2011-03-17 | Lonza Biologics Plc. | Antibody purification by protein A and ion exchange chromatography |
US8263750B2 (en) * | 2006-03-16 | 2012-09-11 | Amgen Inc. | Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step |
JP2010501622A (ja) * | 2006-08-28 | 2010-01-21 | アレス トレーディング ソシエテ アノニム | Fc−融合タンパク質の精製法 |
US20100256337A1 (en) * | 2007-10-22 | 2010-10-07 | Merck Serono Sa | Method for purifying an fc-containing protein |
JP2011514895A (ja) * | 2008-02-29 | 2011-05-12 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 精製免疫グロブリン融合タンパク質およびその精製方法 |
WO2010056550A1 (en) * | 2008-10-29 | 2010-05-20 | Wyeth Llc | Methods for purification of single domain antigen binding molecules |
DK2526114T3 (da) * | 2010-01-22 | 2014-09-29 | Boehringer Ingelheim Int | Kromatografisk fremgangsmåde til oprensning af FC-indeholdende proteiner |
EP2723759A4 (en) * | 2011-06-24 | 2015-01-28 | Reddys Lab Ltd Dr | PURIFICATION OF CHIMERIC PROTEIN |
KR20140043934A (ko) * | 2011-07-08 | 2014-04-11 | 머크 샤프 앤드 돔 코포레이션 | Fc-융합 단백질의 정제 방법 |
KR101454316B1 (ko) * | 2011-08-17 | 2014-10-27 | 한화케미칼 주식회사 | 활성형 TNFR-Fc 융합 단백질을 제조하는 방법 |
WO2013176754A1 (en) | 2012-05-24 | 2013-11-28 | Abbvie Inc. | Novel purification of antibodies using hydrophobic interaction chromatography |
CN102911250B (zh) * | 2012-09-29 | 2014-04-16 | 浙江海正药业股份有限公司 | 酸性重组蛋白药物的纯化方法 |
WO2014159441A1 (en) * | 2013-03-14 | 2014-10-02 | Amgen Inc. | Removal of leaked affinity purification ligand |
-
2015
- 2015-06-13 MA MA040232A patent/MA40232A/fr unknown
- 2015-06-13 CN CN201580038801.XA patent/CN106536565A/zh active Pending
- 2015-06-13 AU AU2015273049A patent/AU2015273049B2/en not_active Ceased
- 2015-06-13 JP JP2016572703A patent/JP6747985B2/ja not_active Expired - Fee Related
- 2015-06-13 MX MX2016016318A patent/MX2016016318A/es unknown
- 2015-06-13 RU RU2017100005A patent/RU2698654C2/ru active
- 2015-06-13 US US15/318,489 patent/US10556942B2/en active Active
- 2015-06-13 BR BR112016029157A patent/BR112016029157A8/pt not_active Application Discontinuation
- 2015-06-13 EP EP15734731.1A patent/EP3155009A1/en not_active Withdrawn
- 2015-06-13 CA CA2951766A patent/CA2951766A1/en not_active Abandoned
- 2015-06-13 WO PCT/IB2015/054494 patent/WO2015189832A1/en active Application Filing
-
2016
- 2016-12-13 PH PH12016502482A patent/PH12016502482A1/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2021284C1 (ru) * | 1991-05-30 | 1994-10-15 | Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов | Способ очистки клинических фракций декстрана |
EA017152B1 (ru) * | 2006-08-28 | 2012-10-30 | Арес Трейдинг С.А. | СПОСОБ ОЧИСТКИ Fc-СОДЕРЖАЩИХ БЕЛКОВ |
US20140072560A1 (en) * | 2012-09-11 | 2014-03-13 | Coherus Biosciences, Inc. | Correctly folded etanercept in high purity and excellent yield |
WO2014078627A1 (en) * | 2012-11-19 | 2014-05-22 | Merck Sharp & Dohme Corp. | Liquid formulations for tnfr:fc fusion proteins |
US20150299249A1 (en) * | 2013-10-18 | 2015-10-22 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
Also Published As
Publication number | Publication date |
---|---|
RU2017100005A3 (ja) | 2019-02-28 |
AU2015273049A1 (en) | 2017-01-12 |
JP2017521389A (ja) | 2017-08-03 |
US20170152298A1 (en) | 2017-06-01 |
MX2016016318A (es) | 2017-06-12 |
PH12016502482A1 (en) | 2017-04-10 |
BR112016029157A8 (pt) | 2021-07-06 |
US10556942B2 (en) | 2020-02-11 |
CA2951766A1 (en) | 2015-12-17 |
RU2017100005A (ru) | 2018-07-13 |
BR112016029157A2 (pt) | 2017-08-22 |
JP6747985B2 (ja) | 2020-08-26 |
WO2015189832A1 (en) | 2015-12-17 |
EP3155009A1 (en) | 2017-04-19 |
MA40232A (fr) | 2017-04-19 |
AU2015273049B2 (en) | 2019-11-14 |
CN106536565A (zh) | 2017-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2698654C2 (ru) | Способ очистки белка слияния | |
JP6216930B2 (ja) | 組換えadamts13および他のタンパク質を精製する方法ならびにそれらの組成物 | |
RU2698392C2 (ru) | Способ очистки фактора свертывания крови viii | |
JP6783767B2 (ja) | 組換えタンパク質を精製する方法 | |
US20140288278A1 (en) | Chromatography process for resolving heterogeneous antibody aggregates | |
RU2731720C2 (ru) | Способ очистки витамин к-зависимых белков, таких как коагуляционный фактор vii | |
US20090318674A1 (en) | Process for purification of antibodies | |
EA017733B1 (ru) | СПОСОБ ОЧИСТКИ Fc-СЛИТЫХ БЕЛКОВ | |
EP3247718A1 (en) | Modulation of charge variants in a monoclonal antibody composition | |
JPWO2011162210A1 (ja) | アミノ酸を利用したタンパク質の精製方法 | |
EP2727930A1 (en) | Method for purifying protein | |
CN102911250B (zh) | 酸性重组蛋白药物的纯化方法 | |
JP2016538267A (ja) | 抗体精製 | |
CN113710685A (zh) | 通过使用捕获前的絮凝改善免疫球蛋白的亲和色谱 | |
JP2023139142A (ja) | 眼科用タンパク質医薬品の精製方法(Refining method of ophthalmic protein pharmaceuticals) | |
JP2023523823A (ja) | タンパク質の精製の改善されたプロセス | |
KR20070091098A (ko) | 단백질 분리 방법 | |
CA3200134A1 (en) | Method of purification of recombinantly-produced rsv proteins in trimeric form | |
CN109929038B (zh) | Vegf捕获剂融合蛋白的纯化方法 | |
RU2769201C2 (ru) | Способ получения высокоочищенного рекомбинантного ингибитора с1-эстеразы человека для медицинского применения | |
JP2023515504A (ja) | 組み換え産生されたポリペプチドの精製 | |
CN114539417A (zh) | 一种有效去除双特异性抗体同源二聚体的层析纯化工艺 | |
CN116670270A (zh) | 控制碱性磷酸酶制造期间的总唾液酸含量(tsac)的方法 | |
Chollangi et al. | ted |